NL-OMON20918尚未招募不适用
Multicenter, double-blind, placebo-controlled, randomized, prospective study of bosentan as adjunctive therapy to inhaled nitric oxide in the management of persistent pulmonary hypertension of the newborn (PPHN).
ACTELION Pharmaceuticals LtdGewerbestrasse 16CH-4123 AllschwilSwitzerland0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Signed informed consent by the parent(s) or the legal representative(s);
- •2. Term and near-term newborns (gestational age > 34 weeks);
排除标准
- •1. PH associated with conditions other than PPHN;
- •2. Immediate need for cardiac resuscitation or extracorporeal membrane oxygenation (ECMO) (profound hypoxemia [PaO2] < 30 mm Hg; OI > 40);
研究者
相似试验
招募中
不适用
A multicenter, double blind placebo controlled randomized trial for Benign esophageal Anastomotic Strictures: Savary dilation vs savary dilation with TriAmcinolon.Patients with dysphagia after esophagectomy with cervical anastomosis due to a benign anastomotic stricture.Patienten met dysfagie na een buismaagreconstructie na slokdarmresectie met een cervicale anastomose veroorzaakt door een benigne anastomotische strictuurNL-OMON26668Maag-, darm-, leverziekten UMC Utrecht60
进行中（未招募）
1 期
A study to find out the safety of BC1036 capsules and to see if it is a useful treatment for patients with a frequent long-term coughEUCTR2011-004589-14-GBRespicopea Limited288
进行中（未招募）
1 期
A placebo controlled Study of Patiromer for the Management of high potassium serum levels in Subjects Receiving a certain group of medications called Renin-Angiotensin-Aldosterone System Inhibitor for treatment of Heart failure.EUCTR2018-005030-38-ITRelypsa Inc878
进行中（未招募）
不适用
A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Standard of Care.-----------------------------------------------------------------------------------------------Estudio multicéntrico, doble ciego, controlado con placebo y aleatorizado de TroVax? frente a placebo en el tratamiento de primera línea de pacientes con cáncer colorrectal metastásico que reciben el tratamiento habitual. - FLAMENCOMetastatic Colorectal Adenocarcinoma.-----------------------------------------------Adenocarcinoma Colorectal Metastásico.MedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2007-005639-26-ESOxford BioMedica1,300
进行中（未招募）
不适用
A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Chemo-based Therapy. - FLAMENCOMetastatic Colorectal AdenocarcinomaMedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2007-005639-26-DEOxford BioMedica (UK) Limited1,312